PYMEPHARCO-STADA AG
General information
Company overview
๐ฆ๐ง๐๐๐ ๐ฃ๐๐บ๐ฒ๐ฝ๐ต๐ฎ๐ฟ๐ฐ๐ผ has been the sole member of STADA Group (Germany) in Vietnam since 2021. As one of the leading pharmaceutical manufacturing companies in Vietnam, we're committed in offering international superior quality medicines at affordable costs. We operate two EU-GMP-certified plants in Tuy Hoa, Phu Yen, with an annual capacity of nearly 3 billion units. Our portfolio includes 400 products, with around 250 generics and 150 consumer healthcare items, including approximately 80 bioequivalent to innovator medicines. In 2024, weโre marking a pivotal moment of our presence by unveiling our new corporate identity and positioning in Vietnam. ๐๐ฎ๐๐ฒ๐ฑ ๐ผ๐ป ๐ผ๐๐ฟ ๐ฝ๐๐ฟ๐ฝ๐ผ๐๐ฒ โ๐๐ฎ๐ฟ๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐ฃ๐ฒ๐ผ๐ฝ๐น๐ฒโ๐ ๐๐ฒ๐ฎ๐น๐๐ต ๐ฎ๐ ๐ฎ ๐๐ฟ๐๐๐๐ฒ๐ฑ ๐ฝ๐ฎ๐ฟ๐๐ป๐ฒ๐ฟโ, ๐ผ๐๐ฟ ๐ฎ๐ถ๐บ ๐ถ๐ ๐๐ผ ๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ โ๐๐ฒ๐ฟ๐บ๐ฎ๐ป ๐๐๐ฎ๐ป๐ฑ๐ฎ๐ฟ๐ฑโ ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ป ๐ฉ๐ถ๐ฒ๐๐ป๐ฎ๐บ ๐ฎ๐ป๐ฑ ๐๐ผ ๐๐ต๐ฒ ๐๐ผ๐ฟ๐น๐ฑ. Our refreshed identity is more than a visual update; it reflects our deep commitment to delivering healthcare at the highest German standards. Our new logo symbolises this dedication to excellence. While we innovate our approach in Vietnam, we inherit the STADA Groupโs Purpose and Vision: โCaring for peopleโs health as a trusted partnerโ, and โTo be the partner of choice in Generics, Specialty, and Consumer Healthcare, while continuously outgrowing the industry in terms of growth and profitability.โ STADAโs Group Core Values of ๐๐ป๐๐ฒ๐ด๐ฟ๐ถ๐๐, ๐๐ป๐๐ฟ๐ฒ๐ฝ๐ฟ๐ฒ๐ป๐ฒ๐๐ฟ๐๐ต๐ถ๐ฝ, ๐๐ด๐ถ๐น๐ถ๐๐ and ๐ข๐ป๐ฒ ๐ฆ๐ง๐๐๐, will continue to guide all our employees' actions and decisions.